Etrumadenant
ARC-6
Phase 2 small_molecule completed
Quick answer
Etrumadenant for Prostatic Neoplasms, Castration-Resistant is a Phase 2 program (small_molecule) at Arcus Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcus Biosciences
- Indication
- Prostatic Neoplasms, Castration-Resistant
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed